Company Overview of Neurotune AG
Neurotune AG discovers and develops therapeutics for the treatment of neuromuscular and central nervous system disorders. The company develops medications for neuropathic pain and sarcopenia (age-related loss of muscle mass and strength). It also develops a platform for the diagnosis and treatment of sarcopenia, as well as a diagnostic immunoassay to measure CAF levels in blood samples. The company was founded in 2005 and is based in Schlieren, Switzerland with an additional office in Bioggio (Ticino), Switzerland.
Wagistrasse 27 a
Founded in 2005
41 44 200 21 95
41 44 200 20 80
Key Executives for Neurotune AG
Similar Private Companies By Industry
|Serono Technologies S.A.||Europe|
|Abbott Products Operations AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Neurotune AG, please visit www.neurotune.com. Company data is provided by Capital IQ. Please use this form to report any data issues.